Former Biogen CFO Michael McDonnell joins Moderna board and Audit Committee

Moderna appointed Michael McDonnell to its board of directors effective July 8, 2026, as a Class II director with a term to the 2029 annual meeting, and to the Audit Committee. McDonnell was Biogen's chief financial officer from August 2020 to February 2025. Chairman Noubar Afeyan and CEO Stephane Bancel tied the appointment to preparing for several possible product launches.

• Joined the board on July 8, 2026 as a Class II director, term to the 2029 annual meeting
• Appointed to the Audit Committee
• Former CFO of Biogen, August 2020 to February 2025